Further Radiobiologic Modeling of Palliative Radiotherapy: Use of Virtual Trials

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 1, 2007, Pages 221-229

  Jones, Bleddyn ^a   Dale, Roger G ^b  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Ions; Palliative; Protons; Radiobiology; Radiotherapy

Indexed keywords

CELLS; COMPUTER SIMULATION; ION BEAMS; MEDICAL PROBLEMS; PROTONS; TUMORS;

PALLIATIVE RADIOTHERAPY; RADIOBIOLOGY; RADIOSENSITIVITY PARAMETERS;

RADIOTHERAPY;

RADIOSENSITIZING AGENT;

ARTICLE; CANCER SURVIVAL; CELL COUNT; CELL KILLING; MODEL; PALLIATIVE THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIOBIOLOGY; RADIOSENSITIVITY; SYMPTOM; TUMOR CELL; TUMOR REGRESSION;

ALGORITHMS; CELL COUNT; CLINICAL TRIALS; DISEASE PROGRESSION; DOSE FRACTIONATION; HUMANS; IONS; LINEAR MODELS; NEOPLASMS; PALLIATIVE CARE; PROTONS; RADIATION INJURIES; RADIATION TOLERANCE; RADIOBIOLOGY; RELATIVE BIOLOGICAL EFFECTIVENESS; REMISSION INDUCTION; TIME FACTORS; TUMOR BURDEN;

EID: 34547838165     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.04.050     Document Type: Article

References (14)

1. Parker R.G., Janjan N.A., and Selch M.T. Radiation oncology for cure and palliation (2003), Springer-Verlag, Berlin p. 10-11, 18-20
2. Jones B., Cominos M., and Dale R.G. Application of biological effective dose (BED) to estimate the duration of symptomatic relief and repopulation dose equivalent in palliative radiotherapy and chemotherapy. Int J Radiat Oncol Biol Phys 55 (2003) 736-742
3. Begg A.C., and Steel G.G. Basic clinical radiobiology. 3rd ed. (2002), Arnold, London p. 8-22
4. Jones B, Sanghera P. Estimation of radiobiological parameters and equivalent radiation dose of cytotoxic chemotherapy in malignant glioma. Int J Radiat Oncol Biol Phys 2007;68:441-448.
5. Fowler J.F. The development of radiobiology for oncology-A personal view. Phys Med Biol 51 (2006) R263-R286
6. Fowler J.F. The linear quadratic formula and progress in fractionated radiotherapy. Br J Radiol 62 (1989) 679-694
7. Singer J.M., Price P., and Dale R.G. Radiobiological prediction of normal tissue toxicities and tumour response in the radiotherapy of advanced non-small-cell lung cancer. Br J Cancer 78 (1998) 1629-1633
8. Wilson D., Hiller L., Gray L., et al. The effect of biological effective dose on time to symptom progression in metastatic renal cell carcinoma. Clin Oncol (R Coll Radiol) 15 (2003) 400-407
9. Tsujii H., Mizoe J.E., Kamada T., et al. Overview of clinical experiences on carbon ion radiotherapy at NIRS. Radiother Oncol 73 Suppl. 2 (2004) S41-S49
10. Jones B. Commentary. HCPBM (Heavy Charged Particles in Biology and Medicine) and ENLIGHT (European Network for Light Ions) Meetings, Oropa (Italy), June 2005. Br J Radiol 79 (2006) 278-284
11. Fowler J.F., Sheldon P.W., Denekamp J., et al. Optimum fractionation of the C3H mouse mammary carcinoma using x-rays, the hypoxic cell sensitiser Ro-07-0582, or fast neutrons. Int J Radiat Oncol Biol Phys 1 (1976) 579-592
12. Rades D., Stalpers L.J., Veninga T., et al. Spinal re-irradiation after short course RT for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys 63 (2005) 872-875
13. Dale R.G. Time-dependent tumour repopulation factors in the linear quadratic equations: Implications for therapeutic strategies. Radiother Oncol 15 (1989) 371-382
14. Jones B., and Dale R.G. The potential for mathematical modelling in the assessment of the radiation dose equivalent of cytotoxic chemotherapy given concomitantly with radiotherapy. Br J Radiol 78 (2005) 939-944